Vimarsana
Biggest News Aggregation in the World

Prof Pandit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prof Pandit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prof Pandit Today - Breaking & Trending Today

Odisha offers Rs 10 crore fund for Biju Patnaik centre for Odia studies at JNU - Vimarsana News

Odisha offers Rs 10 crore fund for Biju Patnaik centre for Odia studies at JNU

The state government will provide a one-time assistance of Rs 10 crore towards the establishment of the centre.

Oxford hospital's boss provides reassurance after Letby murder case - Vimarsana News

Oxford hospital's boss provides reassurance after Letby murder case

Prof Meghana Pandit, the boss of John Radcliffe Hospital, mentioned Lucy Letby's case at the Oxford University Hospitals Trust AGM.

JNU VC Name on viral notice: Conspiracy against me, never had a Twitter account - Vimarsana News

JNU VC Name on viral notice: Conspiracy against me, never had a Twitter account

JNU VC Santishree Dhulipadi Pandit on viral notice: Conspiracy against me, never had a Twitter account - The controversial Twitter account by the name @SantishreeD has now been deactivated. There have been no tweets from the account since May 2021.

New JNU Vice-Chancellor Criticised Over Unverified Handle's Old Tweets - Vimarsana News

New JNU Vice-Chancellor Criticised Over Unverified Handle's Old Tweets

A Twitter account, said to belong to Jawaharlal Nehru University's (JNU) new vice-chancellor Prof Santishree Dhulipadi Pandit, was deactivated yesterday after Twitter users dug out controversial tweets

Source: ndtv.com
Cúram to receive €46.3m from SFI to research new medical treatments - Vimarsana News

Cúram to receive €46.3m from SFI to research new medical treatments

First phase More than 100 researchers are working at Cúram at the moment as it nears the end of its first phase of development, which began when the centre was founded in 2015. Prof Pandit says that around 500 researchers will be needed as it moves into the second phase. “We will be ramping up hiring again in the next three to four months,” he predicts. Among the projects on which Cúram is working is a gel developed by US medical technology company Cerenovus to strengthen heart muscles after a heart attack. Prof Pandit explains that heart attacks weaken the muscle. Cerenovus i...